1 – 100 of 376
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Vector integration and fate in the hemophilia dog liver multi-years following AAV-FVIII gene transfer
2024) In Blood(
- Contribution to journal › Article
-
Mark
Increased risk of venous thromboembolism in young and middle-aged individuals with hereditary angioedema : a family study
2024) In Blood(
- Contribution to journal › Article
- 2021
-
Mark
Genomic and transcriptomic correlates of Richter's transformation in Chronic Lymphocytic Leukemia
(
- Contribution to journal › Article
-
Mark
Platelet EVs contain an active proteasome involved in protein processing for antigen presentation via MHC-I molecules
(
- Contribution to journal › Article
- 2020
-
Mark
Quantitative proteomics reveals specific metabolic features of Acute Myeloid Leukemia stem cells
(
- Contribution to journal › Article
-
Mark
Lysine-specific demethylase 1A (LSD1) restricts ex vivo propagation of human HSCs and is a target of UM171
(
- Contribution to journal › Article
-
Mark
Clonal hematopoiesis evolves from pretreatment clones and stabilizes after end of chemotherapy in patients with MCL
(
- Contribution to journal › Letter
-
Mark
Is the CNS-PINK the new CNS risk model in ENKTL?
(
- Contribution to journal › Article
-
Mark
A Phase I study of inotuzumab ozogamicin in pediatric relapsed/refractory acute lymphoblastic leukemia (ITCC-059 study)
2020) In Blood(
- Contribution to journal › Article
- 2019
-
Mark
Analysis of 153 115 patients with hematological malignancies refines the spectrum of familial risk
(
- Contribution to journal › Article
-
Mark
Timing of inhibitor development in more than 1000 previously untreated patients with severe hemophilia A
(
- Contribution to journal › Letter
-
Mark
Osteopontin mediates murine transfusion-related acute lung injury through stimulation of pulmonary neutrophil accumulation.
(
- Contribution to journal › Article
-
Mark
Transfusion-associated circulatory overload and transfusion-related acute lung injury.
(
- Contribution to journal › Scientific review
- 2018
-
Mark
Genome-wide association study implicates immune dysfunction in the development of Hodgkin lymphoma
(
- Contribution to journal › Article
-
Mark
Allele-selective RUNX1 binding regulates P1 blood group status by transcriptional control of A4GALT
(
- Contribution to journal › Article
-
Mark
Small Molecule Screens Identify CDK8-Inhibitors As Candidate Diamond-Blackfan Anemia Drugs
(
- Contribution to journal › Published meeting abstract
-
Mark
Mouse and human HSPC immobilization in liquid culture by CD43- or CD44-antibody coating
(
- Contribution to journal › Article
- 2017
-
Mark
Single-cell molecular analysis defines therapy response and immunophenotype of stem cell subpopulations in CML
(
- Contribution to journal › Article
-
Mark
Gain-of-function SAMD9L mutations cause a syndrome of cytopenia, immunodeficiency, MDS and neurological symptoms
(
- Contribution to journal › Article
-
Mark
Near-haploid and low hypodiploid acute lymphoblastic leukemia - two distinct subtypes but consistently poor prognosis
(
- Contribution to journal › Article
-
Mark
T regulatory cells and dendritic cells protect against transfusion-related acute lung injury via IL-10
(
- Contribution to journal › Article
- 2016
-
Mark
Gas6 fueling tumor-mediated thrombosis.
(
- Contribution to journal › Article
-
Mark
Diverse roles of cell-specific hypoxia-inducible factor 1 in cancer-associated hypercoagulation.
(
- Contribution to journal › Article
-
Mark
PET-CT for staging & early response: results from 'Response Adapted Therapy in Advanced Hodgkin Lymphoma' (RATHL) (CRUK/07/033).
(
- Contribution to journal › Article
-
Mark
Melphalan, prednisone, and lenalidomide versus melphalan, prednisone, and thalidomide in untreated multiple myeloma.
(
- Contribution to journal › Article
-
Mark
Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations.
(
- Contribution to journal › Article
-
Mark
Lenalidomide-bendamustine-rituximab in untreated mantle cell lymphoma > 65 years, the Nordic Lymphoma Group phase I+II trial NLG-MCL4
(
- Contribution to journal › Article
-
Mark
Move over Tregs, MDSCs are here
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
CD20+ B-cell depletion therapy suppresses murine CD8+ T-cell-mediated immune thrombocytopenia
(
- Contribution to journal › Article
-
Mark
IL1RAP antibodies block IL-1-induced expansion of candidate CML stem cells and mediate cell killing in xenograft models
(
- Contribution to journal › Article
-
Mark
Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease : a multicenter experience
(
- Contribution to journal › Article
-
Mark
Expansion and Biased Commitment of Hematopoietic Stem Cells Towards Erythroid Cells upon Acute Anemia Induction
(
- Contribution to journal › Published meeting abstract
- 2015
-
Mark
Ebf1 heterozygosity results in increased DNA damage in pro-B cells and their synergistic transformation by Pax5 haploinsufficiency.
(
- Contribution to journal › Article
-
Mark
Can a "center effect" explain the higher frequency of inhibitors for a second generation recombinant factor VIII product?
(
- Contribution to journal › Letter
-
Mark
Reflections on the FranceCoag report on inhibitory antibodies to factor VIII in patients with severe hemophilia A.
(
- Contribution to journal › Letter
-
Mark
Population-based study on the impact of the familial form of Waldenström macroglobulinemia on overall survival.
(
- Contribution to journal › Letter
-
Mark
Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations.
(
- Contribution to journal › Article
-
Mark
Central nervous system relapse in peripheral T-cell lymphomas: A Swedish lymphoma registry study.
(
- Contribution to journal › Article
-
Mark
A novel mechanism for NETosis provides antimicrobial defense at the oral mucosa.
(
- Contribution to journal › Article
-
Mark
miR-18b overexpression identifies mantle cell lymphoma patients with poor outcome and improves the MIPI-B prognosticator.
(
- Contribution to journal › Article
-
Mark
TGF-β signaling in the control of hematopoietic stem cells.
(
- Contribution to journal › Article
-
Mark
Jarid2 regulates hematopoietic stem cell function by acting with polycomb repressive complex 2.
(
- Contribution to journal › Article
-
Mark
Outcome and risk factor analysis of molecular subgroups in cytogenetically normal AML treated by allogeneic transplantation.
(
- Contribution to journal › Article
-
Mark
Risk of familial classical Hodgkin lymphoma by relationship, histology, age, and sex: A joint study from five Nordic countries.
(
- Contribution to journal › Article
-
Mark
The first specific antiplatelet antidote.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
FVIII inhibitors: pathogenesis and avoidance.
(
- Contribution to journal › Scientific review
-
Mark
C-reactive protein enhances murine antibody-mediated transfusion-related acute lung injury
(
- Contribution to journal › Article
-
Mark
C-reactive protein boosts antibody-mediated platelet destruction
(
- Contribution to journal › Scientific review
- 2014
-
Mark
HIF-1α can act as a tumor suppressor gene in murine Acute Myeloid Leukemia.
(
- Contribution to journal › Article
-
Mark
Real world data on primary treatment for mantle cell lymphoma: a Nordic Lymphoma Group observational study.
(
- Contribution to journal › Article
-
Mark
Robust isolation of malignant plasma cells in multiple myeloma.
(
- Contribution to journal › Article
-
Mark
Monoclonal gammopathy of undetermined significance and risk of lymphoid and myeloid malignancies: 728 cases followed up to 30 years in Sweden.
(
- Contribution to journal › Article
-
Mark
TFPI cofactor function of protein S: essential role of the protein S SHBG-like domain
(
- Contribution to journal › Article
-
Mark
Mitochondrial DNA copy number and future risk of B-cell lymphoma in a nested case-control study in the prospective EPIC cohort.
(
- Contribution to journal › Article
-
Mark
Real world data on prognostic factors and treatment in peripheral T-cell lymphomas: a study from the Swedish Lymphoma Registry.
(
- Contribution to journal › Article
-
Mark
Analysis of the DNA methylome and transcriptome in granulopoiesis reveals timed changes and dynamic enhancer methylation
(
- Contribution to journal › Article
-
Mark
Nordic MCL3 study: Y-90-ibritumomab-tiuxetan added to BEAM/C in non-CR patients before transplant in mantle cell lymphoma
(
- Contribution to journal › Article
-
Mark
KIR B haplotype donors confer a reduced risk of relapse after haploidentical transplantation in children with acute lymphoblastic leukemia.
(
- Contribution to journal › Article
-
Mark
Risk of RAS in relapsed childhood ALL.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Inherited genetic susceptibility to monoclonal gammopathy of unknown significance
(
- Contribution to journal › Article
-
Mark
Comparing cancer vs normal gene expression profiles identifies new disease entities and common transcriptional programs in AML patients
(
- Contribution to journal › Article
-
Mark
Platelets release mitochondria serving as substrate for bactericidal group IIA-secreted phospholipase A2 to promote inflammation
(
- Contribution to journal › Article
-
Mark
Peripheral blood monocyte-derived chemokine blockade prevents murine transfusion-related acute lung injury (TRALI)
(
- Contribution to journal › Article
-
Mark
Allogeneic platelet transfusions prevent murine T-cell-mediated immune thrombocytopenia
(
- Contribution to journal › Article
-
Mark
Comparison of MRD monitoring by IG/TR rearrangement and BCR/ABL1 transcript in PH+ pediatric acute lymphoblastic leukemia patients treated with imatinib in the EsPhALL study
(
- Contribution to journal › Published meeting abstract
-
Mark
Comprehensive genetic characterization of pediatric T-cell acute lymphoblastic leukemia
(
- Contribution to journal › Published meeting abstract
-
Mark
IL-17 protects T cells from apoptosis and contributes to development of ALPS-like phenotypes
(
- Contribution to journal › Article
- 2013
-
Mark
Intensity of factor VIII treatment and inhibitor development in children with severe hemophilia A: the RODIN study
(
- Contribution to journal › Article
-
Mark
Variation at 10p12.2 and 10p14 influences risk of childhood B-cell acute lymphoblastic leukemia and phenotype
(
- Contribution to journal › Article
-
Mark
Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A
(
- Contribution to journal › Article
-
Mark
The polygenic nature of inhibitors in hemophilia A: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort.
(
- Contribution to journal › Article
-
Mark
Tyrosine kinase inhibitor usage, treatment outcome, and prognostic scores in CML: report from the population-based Swedish CML registry
(
- Contribution to journal › Article
-
Mark
Platelets activated during myocardial infarction release functional miRNA which can be taken up by endothelial cells and regulate ICAM1 expression.
(
- Contribution to journal › Article
-
Mark
Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase 3 trial
(
- Contribution to journal › Article
-
Mark
Non-Hodgkin lymphoma in familial amyloid polyneuropathy patients in Sweden
(
- Contribution to journal › Letter
-
Mark
Intermediate- dose versus high-dose prophylaxis for severe hemophilia: comparing outcome and costs since the 1970s
(
- Contribution to journal › Article
-
Mark
Correlation between phenotype and genotype in a large unselected cohort of children with severe hemophilia A
(
- Contribution to journal › Article
-
Mark
Interfering with histone demethylases in HSCs.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Selective killing of candidate AML stem cells by antibody targeting of IL1RAP.
(
- Contribution to journal › Article
-
Mark
An epigenetic component of hematopoietic stem cell aging amenable to reprogramming into a young state.
(
- Contribution to journal › Article
-
Mark
Forssman expression on human erythrocytes: biochemical and genetic evidence of a new histo-blood group system
(
- Contribution to journal › Article
-
Mark
Identification of the chemokine CCL28 as a growth and survival factor for human hematopoietic stem- and progenitor cells.
(
- Contribution to journal › Article
-
Mark
Platelets deliver small packages of genetic function
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Genetic elimination of the binding motif on fibrinogen for the S. aureus virulence factor ClfA improves host survival in septicemia.
(
- Contribution to journal › Article
-
Mark
A Robust Screening Assay For Diamond Blackfan Anemia Candidate Drugs
(
- Contribution to journal › Published meeting abstract
- 2012
-
Mark
Smad2/Smad3 in endothelium is indispensable for vascular stability via S1PR1 and N-cadherin expressions
(
- Contribution to journal › Article
-
Mark
Emergence of NK cell progenitors and functionally competent NK cell lineage subsets in the early mouse embryo.
(
- Contribution to journal › Article
-
Mark
Second malignancies after multiple myeloma: from 1960s to 2010s
(
- Contribution to journal › Scientific review
-
Mark
Gemtuzumab ozogamicin as postconsolidation therapy does not prevent relapse in children with AML: results from NOPHO-AML 2004
(
- Contribution to journal › Article
-
Mark
Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies
(
- Contribution to journal › Article
-
Mark
F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis
(
- Contribution to journal › Scientific review
-
Mark
Monocytic AML cells inactivate antileukemic lymphocytes: role of NADPH oxidase/gp91(phox) expression and the PARP-1/PAR pathway of apoptosis
(
- Contribution to journal › Article
-
Mark
Adaptor protein Lnk binds to and inhibits normal and leukemic FLT3
(
- Contribution to journal › Article
-
Mark
SRC is a signaling mediator in FLT3-ITD-but not in FLT3-TKD-positive AML
(
- Contribution to journal › Article
-
Mark
HemaExplorer: a Web server for easy and fast visualization of gene expression in normal and malignant hematopoiesis
(
- Contribution to journal › Letter
-
Mark
Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)
(
- Contribution to journal › Article
-
Mark
DNGR-1 is a specific and universal marker of mouse and human Batf3-dependent dendritic cells in lymphoid and nonlymphoid tissues
(
- Contribution to journal › Article
-
Mark
High ERG gene expression is an unfavorable prognostic marker in pediatric acute myeloid leukemia Response
(
- Contribution to journal › Letter
-
Mark
Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry
(
- Contribution to journal › Article
-
Mark
RNAi screen identifies MAPK14 as a druggable suppressor of human hematopoietic stem cell expansion.
(
- Contribution to journal › Article